Celltrion Keeps Pace With Ustekinumab Rivals

Moves CT-P43 Stelara Biosimilar Into Phase III Trials

 
• By David Wallace
  
Running Race Feet
Multiple players are in the race to develop a Stelara biosimilar • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products